A trial which included 124 bone marrow biopsies from patients with MDS, AML and chronic myelomonocytic leukemia (CMML) showed that PD-1, PD-L1, PD-L2 and CTLA4 were upregulated in CD34+ cells. The gene discussed is PDCD1; the disease is acute myeloid leukemia.